SBC Medical Group Holdings Incorporated (SBC)

SBC Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022
Revenue	217.54	193.54	174.16
Revenue Growth (YoY)	-	11.13%	-
Cost of Revenue	61.73	56.24	82.16
Gross Profit	155.8	137.3	92
Selling, General & Admin	57.83	64.33	70.09
Other Operating Expenses	2.06	-0.34	-2.33
Operating Expenses	59.89	63.99	67.76
Operating Income	95.91	73.31	24.25
Interest Expense	-0.02	-0.05	-0.03
Interest & Investment Income	0.04	0.09	0.47
EBT Excluding Unusual Items	95.93	73.36	24.69
Impairment of Goodwill	-	-	-0.25
Gain (Loss) on Sale of Investments	-0.82	0.22	-0.76
Pretax Income	98.92	73.58	23.68
Income Tax Expense	39.33	35.02	18.12
Earnings From Continuing Operations	59.59	38.56	5.55
Minority Interest in Earnings	0.35	0.81	0.76
Net Income	59.94	39.37	6.32
Net Income to Common	59.94	39.37	6.32
Net Income Growth	-	523.44%	-
Shares Outstanding (Basic)	3	3	-
Shares Outstanding (Diluted)	3	3	-
EPS (Basic)	23.66	15.54	-
EPS (Diluted)	23.66	15.54	-
Free Cash Flow	64.23	41.12	-24.99
Free Cash Flow Per Share	25.35	16.23	-
Gross Margin	71.62%	70.94%	52.83%
Operating Margin	44.09%	37.88%	13.92%
Profit Margin	27.55%	20.34%	3.63%
Free Cash Flow Margin	29.53%	21.25%	-14.35%
EBITDA	103.61	85.56	30.18
EBITDA Margin	47.63%	44.21%	17.33%
D&A For EBITDA	7.7	12.25	5.93
EBIT	95.91	73.31	24.25
EBIT Margin	44.09%	37.88%	13.92%
Effective Tax Rate	39.76%	47.59%	76.55%
Revenue as Reported	217.54	193.54	174.16
Advertising Expenses	-	3.37	6.57

Source: S&P Capital IQ. Standard template. Financial Sources.